LYELL IMMUNOPHARMA INC

Q4 2025 13F Holders

Symbol
LYEL
CUSIP
55083R203
Type
Equity
Class
COM NEW
Num filings
71
Total reported value, excl. options
$353 M
Manager Report Date Value ($000) Shares Option Type